Study of KRN951 in Patients With Solid Tumors

NCT00970411 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: KRN951

Sponsor

Kyowa Kirin Co., Ltd.